Published in
Elsevier, Leukemia Research, (97), p. 106429, 2020
DOI: 10.1016/j.leukres.2020.106429
Links
Tools
The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life data
Journal article published in 2020 by
Irit Avivi,
Moshe E. Gatt 
,
Efrat Luttwak ,
Hila Magen,
Najib Dally,
Yael C. Cohen ,
Noam Benyamini,
Noa Lavi
,
Efrat Luttwak ,
Hila Magen,
Najib Dally,
Yael C. Cohen ,
Noam Benyamini,
Noa Lavi
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 